Tag: intracranial haemorrhage
Alveron Pharma closes €5 million seed extension financing to accelerate breakthrough...
Alveron Pharma has announced the closing of a €5 million series seed extension financing—worth approximately US$5.28 million—to advance the development of its innovative drug, OKL-1111,...
Viz.ai and Nico announce collaboration to improve interventional ICH outcomes
Viz.ai has announced a collaboration with Nico Corporation to improve the lives of patients with intracranial haemorrhages (ICHs), leveraging the former’s artificial intelligence (AI)-powered...
Female hormone intake and its influence on cerebral cavernous malformations
As per an observational study published in the journal Neurology last year, female hormone therapy use may be associated with a higher risk of...
Global experts call for tighter standards to speed up emergency haemorrhagic...
An international panel of clinical researchers has published a report in the journal Stroke in which they advocate “immediate change” regarding treatment protocols for...
Apotransferrin shows promise in animal models of intracranial haemorrhage
Researchers from Germans Trias i Pujol Research Institute (IGTP; Badalona, Spain) have discovered that administering human apotransferrin to mice affected by intracranial haemorrhage (ICH)...
Latest trial results prompt call to “elevate” intracranial haemorrhage management
Following the presentation of new trials assessing intracranial haemorrhage (ICH) treatment approaches, INTERACT3 and ENRICH, Craig Anderson (The George Institute for Global Health, Sydney,...
Rapid ICH receives new US FDA clearance with “highest sensitivity and...
RapidAI has announced receipt of US Food and Drug Administration (FDA) 510(k) clearance for the latest release of Rapid ICH—a technology that it describes as...
IRRAS announces educational webinar series alongside Jacobs Institute and University of...
IRRAS today announced the launch of a new educational webinar series, entitled “Exploring the Impact of IRRAflow's Active Fluid Exchange: Our Early Experience Utilizing...
Incidence of brain complications among hospitalised COVID-19 patients revealed in global...
The largest multi-institutional international study to date on brain complications associated with COVID-19 has found that approximately one in 100 patients hospitalised following SARS-CoV-2...
News from SNIS: Bridging therapy independently predicts haemorrhagic complications in atrial...
Exposure to bridging therapy independently predicts haemorrhagic complications—without improving functional outcomes—in patients with atrial fibrillation (AF) associated stroke. The findings from this retrospective, registry...
ISC News: Trend toward benefit in using blood-clotting agent to treat...
Treatment with tranexamic acid, a common medication that reduces bleeding, has led to a non-statistically significant reduction in intracerebral haemorrhage (ICH) growth, both in...
Philips extends AI portfolio with launch of IntelliSpace AI Workflow Suite...
Philips announces the launch of IntelliSpace AI Workflow Suite to enable healthcare providers to seamlessly integrate AI applications into the imaging workflow. Part of...
Aidoc releases complete AI package to speed identification and treatment of...
Aidoc, provider of artificial intelligence (AI) solutions to radiologists, has announced the release of its complete AI package for the identification and triage of...
Overlook Medical Center participates in study evaluating best medical management for...
Overlook Medical Center’s Atlantic Neuroscience Institute is set to participate in the MIND trial: a prospective, multicentre, randomised controlled trial (RCT) examining the Artemis...
Antiplatelet therapy shows “reassuring effects” on the risk of recurrent intracerebral...
“Starting antiplatelet therapy after intracerebral haemorrhage associated with antithrombotic drug use demonstrated reassuring effects on the risk of recurrent haemorrhage,” said Rustam Al-Shahi Salman...
First patient enrolled in haemorrhagic stroke RCT
The first patient has been enrolled in the ENRICH (Early minimally-invasive removal of ICH) randomised clinical trial (RCT). This trial is designed to determine the...
MedyMatch reveals artificial intelligence deep vision intracranial bleed detection technology
MedyMatch Technology has announced that after several years of extensive research and development, it has achieved a major milestone in the availability, for research,...
Data show significant favourable results for NICO BrainPath approach
Two peer-reviewed studies recently published in Neurosurgery and Operative Neurosurgery have shown statistically significant data in favour of the BrainPath approach (NICO), citing more...
NICO announces BrainPath haemorrhagic stroke trial
Two of Atlanta’s stroke centres, associated with Emory University School of Medicine, have joined NICO (Neurosurgical Intervention Company) to perform a randomised controlled trial...
